http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-49596-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
filingDate 1997-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22dba43a84cabc5f2d28b551dfb23a45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05c15046003e70bb79a6ee68bdbba970
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0d0120eca0f6cffadff36929ab90175
publicationDate 2007-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RS-49596-B
titleOfInvention APPLICATION OF PHARMACEUTICAL COMPOSITION FOR GEL GOODS
abstract Use of a pharmaceutical composition comprising a hydrophilic gel-forming agent, water, wetting and dispersing agents and compounds according to formula I or a physiologically acceptable salt of a compound according to formula I, wherein R 1, R 2 and R 3 are the same or different, represent a hydrogen atom or an alkyl group with 1 to 4 carbon atoms, and R4 represents a saturated hydrocarbon with 6 to 9 carbon atoms, to obtain a drug in the form of a gel for the treatment and prophylaxis of skin mycoses. The application contains another 12 patent claims.
priorityDate 1996-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 35.